Speaker illustration

Ms Fany Bonilla

Spring House (United States of America)

Comparison of the sensitivity of commercial aPTT tests in measurement of the pharmacodynamic response of milvexian, a novel FXIa inhibitor

Event: ESC Congress 2021 - The Digital Experience

Topic: Anticoagulants

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb